课题基金 / 基金详情

TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS

TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS
针对特定病毒感染的有针对性的临床研究
批准号：
9467404
负责人：
DAVID KIMBERLIN
金额：
$260.87万
依托单位：
UNIVERSITY OF ALABAMA AT BIRMINGHAM
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
项目状态：
已结题
起止时间：
2016-07-01 至 2021-06-30
来源：
https://reporter.nih.gov/project-details/9467404
关键词：
AddressAdvanced DevelopmentChildhoodClinical Course of DiseaseClinical ResearchCytomegalovirus InfectionsEmerging Communicable DiseasesMedicalPopulationResearchTherapeuticVirus Diseasespatient populationtherapeutic development

项目摘要

项目成果

DAVID KIMBERLIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To advance the development of therapeutic strategies for rare and/or emerging viral diseases of medical importance in targeted patient populations by 1) characterizing contemporary course of the clinical disease, and/or 2) directly evaluating a therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Natural History Study of Acute Flaccid Myelitis (AFM)
TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS
TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS
海外基金